A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis

To test the feasibility and efficacy of epirubicin and ifosfamide added to first-line chemotherapy with cisplatin and paclitaxel in a phase II randomised clinical trial. Patients with histologically proven epithelial ovarian cancer were randomly assigned to receive first-line polychemotherapy with c...

Descripción completa

Detalles Bibliográficos
Autores principales: Fruscio, R, Colombo, N, Lissoni, A A, Garbi, A, Fossati, R, Ieda', N, Torri, V, Mangioni, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259172/
https://www.ncbi.nlm.nih.gov/pubmed/18253120
http://dx.doi.org/10.1038/sj.bjc.6604231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259172/
https://www.ncbi.nlm.nih.gov/pubmed/18253120
http://dx.doi.org/10.1038/sj.bjc.6604231

Ejemplares similares